{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:15:45Z","timestamp":1778868945833,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26461533"],"award-info":[{"award-number":["26461533"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007962","name":"Jikei University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109224h003"],"award-info":[{"award-number":["19ek0109224h003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.omtm.2020.09.012","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T10:35:46Z","timestamp":1600598146000},"page":"261-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Ex\u00a0Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation"],"prefix":"10.1016","volume":"19","author":[{"given":"Miho","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohta","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoko","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoutaro","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.omtm.2020.09.012_bib1","doi-asserted-by":"crossref","first-page":"v19","DOI":"10.1093\/rheumatology\/ker397","article-title":"Musculoskeletal manifestations of mucopolysaccharidoses","volume":"50","author":"Morishita","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 5","key":"10.1016\/j.omtm.2020.09.012_bib2","doi-asserted-by":"crossref","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50","author":"White","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.omtm.2020.09.012_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.03.004","article-title":"Growth impairment in mucopolysaccharidoses","volume":"124","author":"Melbouci","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl 2","key":"10.1016\/j.omtm.2020.09.012_bib4","first-page":"406","article-title":"Skeletal abnormalities in lysosomal storage diseases","volume":"10","author":"Stevenson","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.omtm.2020.09.012_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.09.012_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2020.09.012_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10545-008-0878-x","article-title":"Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed","volume":"31","author":"Al Sawaf","year":"2008","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","article-title":"Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy","volume":"34","author":"Manara","year":"2011","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.omtm.2020.09.012_bib11","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00246-013-0653-0","article-title":"Massive accumulation of glycosaminoglycans in the aortic valve of a patient with Hunter syndrome during enzyme replacement therapy","volume":"34","author":"Sato","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.omtm.2020.09.012_bib12","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2005-03-1189","article-title":"Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology","volume":"106","author":"Sano","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.09.012_bib13","first-page":"2","article-title":"Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients","volume":"12","author":"Giugliani","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2020.09.012_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00710053","article-title":"Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation","volume":"18","author":"Shapiro","year":"1995","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(96)70202-0","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"129","author":"McKinnis","year":"1996","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2020.09.012_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2020.09.012_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ymgme.2013.09.013","article-title":"Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice","volume":"111","author":"Akiyama","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.09.012_bib20","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.09.012_bib21","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.09.012_bib22","doi-asserted-by":"crossref","first-page":"987980","DOI":"10.4061\/2011\/987980","article-title":"The ongoing challenge of hematopoietic stem cell-based gene therapy for \u03b2-thalassemia","volume":"2011","author":"Drakopoulou","year":"2011","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.omtm.2020.09.012_bib23","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.09.012_bib24","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/mt.2012.82","article-title":"Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice","volume":"20","author":"Langford-Smith","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/hum.2014.158","article-title":"Hematopoietic stem cell gene therapy corrects neuropathic phenotype in murine model of mucopolysaccharidosis type II","volume":"26","author":"Wakabayashi","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib27","first-page":"7075","article-title":"Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I","volume":"24","author":"Kuehn","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.09.012_bib28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2014-06-581207","article-title":"Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I","volume":"125","author":"Pievani","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.09.012_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymgme.2016.09.003","article-title":"Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy","volume":"119","author":"Derrick-Roberts","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)","volume":"30","author":"Garcia","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2020.09.012_bib31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.09.012_bib32","doi-asserted-by":"crossref","first-page":"e0172435","DOI":"10.1371\/journal.pone.0172435","article-title":"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of mucopolysaccharidosis type II","volume":"12","author":"Gleitz","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.09.012_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajhg.2009.07.011","article-title":"IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice","volume":"85","author":"Polito","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2020.09.012_bib34","doi-asserted-by":"crossref","first-page":"e8730","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2020.09.012_bib35","doi-asserted-by":"crossref","first-page":"e86696","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2020.09.012_bib36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/hum.2013.141","article-title":"Lentiviral-mediated gene therapy results in sustained expression of \u03b2-glucuronidase for up to 12\u00a0months in the Gusmps\/mps and up to 18\u00a0months in the Gustm(L175F)Sly mouse models of mucopolysaccharidosis type VII","volume":"25","author":"Derrick-Roberts","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2012.03.022","article-title":"Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII","volume":"106","author":"Macsai","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib38","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1016\/j.biomaterials.2013.06.053","article-title":"The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-\u03baB ligand\/osteoprotegerin complex formation","volume":"34","author":"Salbach-Hirsch","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2020.09.012_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5312\/wjo.v4.i4.186","article-title":"Historically significant events in the discovery of RANK\/RANKL\/OPG","volume":"4","author":"Martin","year":"2013","journal-title":"World J. Orthop."},{"key":"10.1016\/j.omtm.2020.09.012_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00109-012-0974-0","article-title":"Roles of Wnt signals in bone resorption during physiological and pathological states","volume":"91","author":"Maeda","year":"2013","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtm.2020.09.012_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00198-008-0658-3","article-title":"Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain","volume":"20","author":"Dumas","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtm.2020.09.012_bib42","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jbmr.2458","article-title":"Single-limb irradiation induces local and systemic bone loss in a murine model","volume":"30","author":"Wright","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.09.012_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2474-10-66","article-title":"The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis","volume":"10","author":"Shiraishi","year":"2009","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.omtm.2020.09.012_bib44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S8756-3282(02)00850-5","article-title":"Unique alignment and texture of biological apatite crystallites in typical calcified tissues analyzed by microbeam X-ray diffractometer system","volume":"31","author":"Nakano","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.omtm.2020.09.012_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtm.2020.09.012_bib46","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.09.012_bib47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2020.09.012_bib48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib49","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/mt.2012.136","article-title":"Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression","volume":"20","author":"Falahati","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2012.05.005","article-title":"Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II","volume":"107","author":"Higuchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ymgme.2015.05.009","article-title":"A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice","volume":"117","author":"Shimada","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2017.12.428","article-title":"Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II","volume":"123","author":"Hoshina","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2020.09.012_bib53","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/mt.2012.133","article-title":"Administration of anti-CD3 antibodies modulates the immune response to an infusion of \u03b1-glucosidase in mice","volume":"20","author":"Ohashi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib54","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.mt.6300180","article-title":"Lentiviral vectors with CMV or MHCII promoters administered in\u00a0vivo: immune reactivity versus persistence of expression","volume":"15","author":"Kimura","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/mthe.2002.0594","article-title":"Enhanced secretion and uptake of \u03b2-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice","volume":"5","author":"Elliger","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.09.012_bib56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.09.012_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00198-009-0980-4","article-title":"Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.omtm.2020.09.012_bib58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S8756-3282(98)00076-3","article-title":"Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia","volume":"23","author":"J\u00e4ms\u00e4","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.omtm.2020.09.012_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2017.06.023","article-title":"Co-deteriorations of anisotropic extracellular matrix arrangement and intrinsic mechanical property in c-src deficient osteopetrotic mouse femur","volume":"103","author":"Ishimoto","year":"2017","journal-title":"Bone"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:52:22Z","timestamp":1778867542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":59,"alternative-id":["S2329050120301972"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.09.012","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex\u00a0Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}